Dr Jason Kantor of RBC Capital Markets said he sees a continuing trend toward biologics in the biotech space. Biologics are drugs or therapies created by the biological process rather than through chemistry, and include gene therapies, proteins, antibodies, tissues, cells, and other biological products. One company that may be positioned to take advantage of that trend is Seattle Genetics.

David Ku, long time SVP for a dvertising. Products is calling it quits. What a drag, he was very effective. Did Carol Bartz do this? Things are looking bad over there. The company she helped found to focus on jazz. Srinivasan, 38, joined Yahoo in 1995 as its fifth employee, announced her departure on a Yahoo blog. Does it matter anymore? Yester.

True diversification in a mutual fund. Oliver Pursche, co-portfolio manager of Montebello Partners, which runs the fund, recently explained the strategy and benefits of MPDAX in an interview. With The Wall Street Transcrip.

On October 21, 2010. 36 billion, according to an AP report. Chief Financial Officer Tom Szkutak. Used to prompt user experience. We will see this in areas such as r.

Mitsui Fudosan Gets Lumped In. In light of the problems in the Japanese real estate market. Over the last year- overleveraged REITs, a pull out by foreign companies and many other issues- the space as a whole has been hit hard by investors. One portfolio manager, however, took the time to take a bottom-up look at one company, and has come up with strong pick, in his estimation. In a recent interview with The Wall Street Transcript.